Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome

Recent advances in understanding the pathophysiological mechanisms contributing to fragile X syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....

Descripción completa

Detalles Bibliográficos
Autores principales: Mines, Marjelo A., Jope, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205455/
https://www.ncbi.nlm.nih.gov/pubmed/22053151
http://dx.doi.org/10.3389/fnmol.2011.00035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205455/
https://www.ncbi.nlm.nih.gov/pubmed/22053151
http://dx.doi.org/10.3389/fnmol.2011.00035

Ejemplares similares